Latest Releases
U.S. Senator Tina Smith Joins Elizabeth Warren, Banking Committee Democrats in Pressing SEC Chair to Require Disclosure of Corporate Lobbying Expenditures
Washington, D.C. — Today, U.S. Senators Tina Smith (D – Minn.), Sherrod Brown (D-Ohio.), Jon Tester (D-Mont.) and John Fetterman (D-Pa.) signed onto a letter led by Senator Elizabeth Warren (D – Mass.) urging Gary Gensler, Chair of the U.S. Securities and Exchange Commission (SEC), to create new rules requiring public companies to disclose their spending on lobbying efforts. Public companies are not currently required to report information on the details of their lobbying to the SEC even as corporate lobbying expenditures reach record highs. “In 2022, total federal lobbying expenditures reached $4.1 billion – the highest since 2010. Amazon and Meta spent almost $20 million each to influence decision-making in Congress and across government agencies, while the U.S. Chamber of Commerce – which counts companies like JPMorgan Chase, Alphabet, and Chevron among its members – spent $79.4 million,” wrote the senators. “While these figures are staggering, they provide little insight into the interests that companies spend millions each year to advance. This lack of transparency erodes the ability of everyday investors to make informed decisions about where to invest their money – and where their money goes once they have invested.” Specifically, the senators are requesting that such rules require disclosure of lobbying strategy, the total amount of direct or indirect contributions to registered state and federal lobbyists and any material risks related to or arising from lobbying strategies and expenditures. The senators requested the SEC provide them with details on their plans to develop and issue such rules no later than
U.S. Senators Tina Smith, Tom Cotton Reintroduce Bipartisan Legislation to Boost U.S. Pharmaceutical Manufacturing
WASHINGTON, D.C. — Today, Senators Tina Smith (D-MN) and Tom Cotton (R-AR) reintroduced bipartisan legislation to reduce dependence on foreign pharmaceutical manufacturing and boost production in the U.S. The pandemic exposed our nation’s dependence on other countries for essential prescription drugs. Seventy-seven percent of key pharmaceutical ingredients come from overseas, including from China, threatening the security of the supply chain and leading to shortages of essential prescription drugs. The American Made Pharmaceuticals Act would reduce our dependence on foreign countries for pharmaceuticals by boosting production here at home. The legislation would create federal incentives to onshore manufacturing of essential medicine, while taking steps to shore up links in the supply chain. “We know that depending on foreign countries for key resources – whether it’s oil or medicine – leaves us vulnerable to global supply chain shocks and shortages,” said Sen. Smith. “This bipartisan legislation would reduce our dependence on foreign pharmaceutical manufacturing and help boost production here at home. I look forward to getting this bill across the finish line so we can relieve prescription drug shortages and build more resilient supply chains.” “The Chinese Communist Party threatened to cut off America’s access to vital drugs during the pandemic,” said Sen. Cotton. “It’s time to bolster onshore manufacturing of pharmaceuticals to ensure Americans never have to rely on China for lifesaving medicine.” “Amneal applauds Senators Smith and Cotton on their targeted approach to increase pharmaceutical manufacturing here in the United States,” said Chirag Patel, President & Co-CEO of Amneal Pharmaceuticals. “Ensuring that
U.S. Senator Tina Smith: Trump’s New Farm Aid “A Little Band-Aid for a Big, Ugly Problem”
**VIDEO RELEASE** WASHINGTON, D.C. [05/24/2019]—In an interview this week on Bloomberg TV, U.S. Sen. Tina Smith (D-Minn.) discussed the challenges facing farmers and rural communities, and characterized the Trump Administration’s recently announced aid as “a little Band-Aid for a big, ugly problem.” You can watch the video of her full interview here. “I don’t know a single farm that wouldn’t see that and say, sure, I’m happy to accept a helping hand because I’m really hurting right now,” said Sen. Smith—a member of the Senate Ag Committee. “But what I think most farmers in Minnesota would say is that’s a
Klobuchar and Smith Hail Senate Passage of Bipartisan Bill to Crack Down on Robocalls
WASHINGTON, D.C. [05/23/19] – Today, U.S. Senators Amy Klobuchar (D-MN) and Tina Smith (D-MN) lauded Senate passage of a bill they championed that will increase penalties against telemarketers who spam Americans with robocalls and promote call authentication and blocking technologies. Robocalls are on the rise, with one source reporting an increase of 50% in robocall volume from February to July of last year. The bipartisan Telephone Robocall Abuse Criminal Enforcement and Deterrence (TRACED) Act passed in the Senate today would increase penalties for fraudulent telemarketers, while also implementing measures to proactively protect consumers from receiving unwanted robocalls. The bipartisan bill was
U.S. Senator Tina Smith’s Key Health Care Priorities Included in Larger, Bipartisan Health Care Costs Package
WASHINGTON, D.C. [05/23/2019]—A number of measures championed by U.S. Senator Tina Smith (D-Minn.) were included in the bipartisan package to address the rising cost of health care released today by the Senate Health Committee, including Sen. Smith’s efforts to help bring lower-cost insulin and generic drugs to market. Sen. Smith said both her bipartisan Protecting Access to Biosimilars Act and the Ensuring Innovation Act were added to the package, and her work with colleagues to increase price transparency by strengthening health care databases is also included. “The high costs of health care are jeopardizing the financial security of Americans and
U.S. Senators Tina Smith, Susan Collins Address Rise in Tick-Borne Diseases and Introduce Bipartisan Legislation to Target, Prevent, and Treat Lyme Disease
WASHINGTON, D.C. [05/23/19]—Today, U.S. Senators Tina Smith (D-Minn.) and Susan Collins (R-Maine), in a bipartisan effort, pushed for improving research and treatment efforts that address the sharp rise in tick-borne diseases. The Ticks: Identify, Control, and Knockout (TICK) Act, improves coordination between government response at the federal and local levels to tick borne diseases. “Minnesotans are eager to get outside after a long winter,” said Sen. Smith, a member of the Senate Health Committee. “Unfortunately, the number of Lyme disease cases in the state—and states across the country—is on the rise. Our bipartisan bill aims to reduce the number of
English